Colgate-Palmolive Company [NYSE: CL] opened at $70.87 and closed at $70.52 a share within trading session on 15/08/2019. That means that the stock gained by 1.21% compared to the closing price from a day before, when the stock touched $71.37.
Between the start and the closing of the latest trading session, Colgate-Palmolive Company [NYSE: CL] had 3.7 million shares being bought and sold. In the last three months, average trading volumes hovered around 3.37M shares. During the last week, volatility in the share price was set at 1.66%, which placed the metric for the last 30 days at 2.12%. The price of the stock additionally went down to $57.41 during that period and CL managed to take a rebound to $76.41 in the last 52 weeks.
Colgate-Palmolive Company [NYSE:CL]: Analyst Rating and Earnings
Stock traders often pay close attention what Wall Street analysts have to say about a potential investment. For Colgate-Palmolive Company [CL], the latest consensus recommendation available followed its financial results for the fiscal quarter ending in December. On average, stock market experts give CL an Hold rating. Its stock price has been found in the range of 57.41 to 76.41. This is compared to its latest closing price of $70.52.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Colgate-Palmolive Company [CL] is sitting at 2.71. This is compared to 1 month ago, when its average rating was 2.76.
For the quarter ending in Jun-19 Colgate-Palmolive Company [CL] generated $3.87 billion in sales. That’s 0.27% lower than the average estimate of $3.88 billion as provided by Wall Street analysts. The three indicators above suggest that overall, this stock is demonstrating a mixed bag of positive appeal and some drawbacks, making it a somewhat risky investment that also has the potential to generate high ROI in the long run.
Keep an eye out for the next scheduled publication date for this company’s financial results, which are expected to be released on Fri 25 Oct (In 71 Days).
Fundamental Analysis of Colgate-Palmolive Company [CL]
Now let’s turn to look at profitability: with a current Operating Margin for Colgate-Palmolive Company [CL] sitting at +24.77 and its Gross Margin at +59.23, this company’s Net Margin is now 14.80%. These measurements indicate that Colgate-Palmolive Company [CL] is generating considerably more profit, after expenses are accounted for, compared to its market peers.
This company’s Return on Total Capital is 57.54, and its Return on Invested Capital has reached 45.60%. Its Return on Assets is 19.33.
Similarly, its Total Debt to Total Capital is 101.63, while its Total Debt to Total Assets stands at 52.35.
What about valuation? This company’s Enterprise Value to EBITDA is 15.36 and its Total Debt to EBITDA Value is 1.46. The Enterprise Value to Sales for this firm is now 4.35, and its Total Debt to Enterprise Value stands at 0.11.
Shifting the focus to workforce efficiency, Colgate-Palmolive Company [CL] earns $450,551 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 10.79 and its Total Asset Turnover is 1.25. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 0.76 and its Current Ratio is 1.14. This company is not investing its short-term assets in an optimally efficient way, making it a riskier investment.
Colgate-Palmolive Company [CL] has 860.29M shares outstanding, amounting to a total market cap of $61.40B. Its stock price has been found in the range of 57.41 to 76.41. At its current price, it has moved down by -6.60% from its 52-week high, and it has moved up 24.32% from its 52-week low.
This stock’s Beta value is currently 0.75, which indicates that it is 1.66% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 47.71. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Colgate-Palmolive Company [CL] a Reliable Buy?
Shares of Colgate-Palmolive Company [CL], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.